BORA PHARMACEUTICAL LABORATOIRES

Bora Pharmaceutical Laboratories Inc. is a factory.

Company Introduction:

Bora Pharmaceutical Laboratories Inc. is a leading Contract Development and Manufacturing Organization (CDMO) based in Taiwan. The company primarily operates as a manufacturer, providing a comprehensive suite of pharmaceutical development and manufacturing services to global pharmaceutical and biotech clients.

Bora's core business involves the production of pharmaceutical products. Their services include:

Research and Development (R&D)

Formulation development

Clinical trial material manufacturing

Commercial manufacturing of various dosage forms, such as oral solids, liquids, and semi-solids

Packaging

Analytical testing

The company is distinguished by its integrated services, adherence to international cGMP (current Good Manufacturing Practice) standards, and its capability to manage complex pharmaceutical projects from early development stages through to commercialization. As a CDMO, its primary function is the manufacturing and supply of pharmaceutical products for its partners, positioning it firmly as a factory rather than a trading company.

Bora Pharmaceuticals Product Portfolio and Services

Manufacturing and Sales Categories:

1. CDMO Services (Contract Development and Manufacturing Organization)

Bora provides comprehensive contract manufacturing services for global partners, including oral solid dosages, liquids, semi-solids, and specialized niche products.

2. Key Therapeutic Areas of Produced/Distributed Products

Gastrointestinal health

Central Nervous System (CNS) medications

Cardiovascular treatments

Dermatological products

Pain management

Metabolic disease medications

3. Notable Product Examples (Representative Portfolio)

Evista (Raloxifene) for osteoporosis

Adalat (Nifedipine) for hypertension and angina

Various proprietary and licensed generic medications for the international market

Multiple ophthalmic and topical formulations (following the acquisition of Upsher-Smith Laboratories)

4. Market Presence

The company operates as a global pharmaceutical manufacturer with a strong focus on the North American, Asian, and European markets, specializing in high-barrier-to-entry formulations and complex manufacturing processes.

Note: As a CDMO, the company manufactures a wide array of products under private labels and partnership agreements. Specific product names may vary by regional distribution rights and active licensing contracts.